Blog

  • Tracy K. Smith, the New Poet Laureate: “Her work travels the world and takes on its voices; brings history and memory to life”

    Tracy K. Smith (Photo Credit: Rachel Eliza Griffiths)Tracy K. Smith, US Poet Laureate, 2017 –  Photo credit: Rachel Eliza Griffiths

    Librarian of Congress Carla Hayden appointed Tracy K. Smith as the Library’s 22nd Poet Laureate Consultant in Poetry on June 14, 2017. 

     

    Tracy K. Smith was born in Falmouth, Massachusetts in 1972, and raised in Fairfield, California. She is the author of three books of poetry, including Life on Mars (2011), winner of the 2012 Pulitzer Prize for Poetry; Duende (2007), winner of the 2006 James Laughlin Award and the 2008 Essence Literary Award; and The Body’s Question (2003), winner of the Cave Canem Poetry Prize. Smith is also the author of a memoir, Ordinary Light (2015), a finalist for the 2015 National Book Award in Nonfiction and selected as a Notable Book by The New York Times and The Washington Post.

    Here’s the news release announcing the appointment:

    Smith, a Pulitzer Prize-winning poet and a professor at Princeton University, succeeds Juan Felipe Herrera as Poet Laureate.

    “It gives me great pleasure to appoint Tracy K. Smith, a poet of searching,” Hayden said. “Her work travels the world and takes on its voices; brings history and memory to life; calls on the power of literature as well as science, religion and pop culture. With directness and deftness, she contends with the heavens or plumbs our inner depths — all to better understand what makes us most human.”

    “I am profoundly honored,” Smith said. “As someone who has been sustained by poems and poets, I understand the powerful and necessary role poetry can play in sustaining a rich inner life and fostering a mindful, empathic and resourceful culture. I am eager to share the good news of poetry with readers and future readers across this marvelously diverse country.”

    Smith joins a long line of distinguished poets who have served in the position, including Juan Felipe Herrera, Charles Wright, Natasha Trethewey, Philip Levine, W.S. Merwin, Kay Ryan, Charles Simic, Donald Hall, Ted Kooser, Louise Glück, Billy Collins, Stanley Kunitz, Robert Pinsky, Robert Hass and Rita Dove.

    The new Poet Laureate is the author of three books of poetry, including Life on Mars  (2011), winner of the 2012 Pulitzer Prize for Poetry; Duende (2007), winner of the 2006 James Laughlin Award and the 2008 Essence Literary Award; and The Body’s Question (2003), winner of the Cave Canem Poetry Prize. Smith is also the author of a memoir, Ordinary Light (2015), a finalist for the 2015 National Book Award in nonfiction and selected as a notable book by The New York Times and the Washington Post.

    For her poetry, Smith has received a Rona Jaffe Writers Award and a Whiting Award. In 2014, the Academy of American Poets awarded her with the Academy Fellowship, given to one poet each year to recognize distinguished poetic achievement. In 2016, she won the 16th annual Robert Creeley Award and was awarded Columbia University’s Medal for Excellence.

    In the Pulitzer Prize citation for Life on Mars, judges lauded its “bold, skillful poems, taking readers into the universe and moving them to an authentic mix of joy and pain.” Toi Derricotte, poet, and Academy of American Poets Chancellor, said “the surfaces of a Tracy K. Smith poem are beautiful and serene, but underneath, there is always a sense of an unknown vastness. Her poems take the risk of inviting us to imagine, as the poet does, what it is to travel in another person’s shoes.”

    Born in Falmouth, Massachusetts in 1972, and raised in Fairfield, California, Tracy K. Smith earned a B.A. in English and American literature and Afro-American studies from Harvard University and an M.F.A. in creative writing from Columbia University. From 1997 to 1999, she was a Stegner Fellow in poetry at Stanford University. Smith has taught at Medgar Evers College of the City University of New York, at the University of Pittsburgh and at Columbia University. She is currently the Roger S. Berlind ’52 Professor in the Humanities and director of the creative writing program at Princeton University.

  • California’s Aid-In-Dying Law Turns One Year Old, But Not All Doctors Have Adopted It

    John Minor was one of about 500 Californians to be prescribed lethal medication under the state’s aid-in-dying law. Minor is pictured with his daughter Valerie Minor Johnson on Sept. 15, 2016 — the day he ended his life. (Photo courtesy of the Minor family.)

    John Minor of Manhattan Beach epitomized the active Californian. The retired psychologist was a distance runner, a cyclist and an avid outdoorsman, says his daughter Jackie Minor of San Mateo.

    “He and my mom were both members of the Sierra Club,” Jackie said. “They went on tons of backpacking trips — climbing mountains and trekking through the desert. He was just a very active person.”

    But in September 2014, he fell ill with terminal pulmonary fibrosis — a lung disease that his family says slowly eroded his quality of life.

    Two years after that diagnosis, last September 15, John Minor, surrounded by his family, sipped his last drink: apple juice laced with a lethal dose of medication his doctor had prescribed for him. He was 80.

    “He laid down and went to sleep and he was in a coma for about two hours and then he — passed,” Jackie said. “It was very peaceful.”

    The organization reports that nearly 500 hospitals and health systems and more than 100 hospice organizations allow aid-in-dying to be offered to their patients and 80 percent of insurers statewide cover expenses related to it. The California law created a process for dying patients to ask their doctors for a lethal prescription that they can then take privately, at home.

    “What the numbers are showing is that the law is working incredibly well,” said Matt Whitaker, the organization’s point person for California and Oregon which both have aid-in-dying laws. “That it’s working as the lawmakers intended.” 

    Still, for some patients, finding a doctor willing to prescribe the life-ending drugs can be difficult, in part because the law allows doctors to opt out of prescribing – even when the hospital where they work has agreed to participate in assisting patients.

    “It’s a very nuanced decision,” said Dr. Elizabeth Dzeng, an assistant professor of hospital medicine at the University of California, San Francisco, where, she estimates, about three dozen patients have made the request so far. Dzeng said the decision to prescribe doesn’t come easy for many doctors.

    “Even if they’re in support of aid-in-dying they don’t necessarily want to be the person identified as the go-to person for aid-in-dying because that’s a very different implication,” she said.

  • Message from the Fed: The Labor Market Has Continued to Strengthen and Economic Activity Has Been Rising Moderately So Far This Year

     

    Janet Yellen

    Federal Reserve Chairwoman Janet Yellen

    Information received since the Federal Open Market Committee met in May indicates that the labor market has continued to strengthen and that economic activity has been rising moderately so far this year. Job gains have moderated but have been solid, on average, since the beginning of the year, and the unemployment rate has declined. Household spending has picked up in recent months, and business fixed investment has continued to expand. On a 12-month basis, inflation has declined recently and, like the measure excluding food and energy prices, is running somewhat below 2 percent. Market-based measures of inflation compensation remain low; survey-based measures of longer-term inflation expectations are little changed, on balance.

    Consistent with its statutory mandate, the Committee seeks to foster maximum employment and price stability. The Committee continues to expect that, with gradual adjustments in the stance of monetary policy, economic activity will expand at a moderate pace, and labor market conditions will strengthen somewhat further. Inflation on a 12-month basis is expected to remain somewhat below 2 percent in the near term but to stabilize around the Committee’s 2 percent objective over the medium term. Near term risks to the economic outlook appear roughly balanced, but the Committee is monitoring inflation developments closely.

    In view of realized and expected labor market conditions and inflation, the Committee decided to raise the target range for the federal funds rate to 1 to 1-1/4 percent. The stance of monetary policy remains accommodative, thereby supporting some further strengthening in labor market conditions and a sustained return to 2 percent inflation.

    In determining the timing and size of future adjustments to the target range for the federal funds rate, the Committee will assess realized and expected economic conditions relative to its objectives of maximum employment and 2 percent inflation. This assessment will take into account a wide range of information, including measures of labor market conditions, indicators of inflation pressures and inflation expectations, and readings on financial and international developments. The Committee will carefully monitor actual and expected inflation developments relative to its symmetric inflation goal. The Committee expects that economic conditions will evolve in a manner that will warrant gradual increases in the federal funds rate; the federal funds rate is likely to remain, for some time, below levels that are expected to prevail in the longer run. However, the actual path of the federal funds rate will depend on the economic outlook as informed by incoming data.

    The Committee is maintaining its existing policy of reinvesting principal payments from its holdings of agency debt and agency mortgage-backed securities in agency mortgage-backed securities and of rolling over maturing Treasury securities at auction. The Committee currently expects to begin implementing a balance sheet normalization program this year, provided that the economy evolves broadly as anticipated. This program, which would gradually reduce the Federal Reserve’s securities holdings by decreasing reinvestment of principal payments from those securities, is described in the accompanying addendum to the Committee’s Policy Normalization Principles and Plans.

    Voting for the FOMC monetary policy action were: Janet L. Yellen, Chair; William C. Dudley, Vice Chairman; Lael Brainard; Charles L. Evans; Stanley Fischer; Patrick Harker; Robert S. Kaplan; and Jerome H. Powell. Voting against the action was Neel Kashkari, who preferred at this meeting to maintain the existing target range for the federal funds rate.

    Implementation Note issued June 14, 2017

  • The ‘Stereoscopic’ Vision of Dressmakers; Are Dressmakers Drawn to the Trade Because of Their Visual Stereo-acuity?

    By Yasmin Anwar

    Haute couture can be credited for enhancing more than catwalks and red carpets. New research from UC Berkeley suggests that the 3D or ‘stereoscopic’ vision of dressmakers is as sharp as their needles.

    Stereoscopic vision is the brain’s ability to decode the flat 2D optical information received by both eyes to give us the depth of perception needed to thread a needle, catch a ball, park a car and generally navigate a 3D world.  Using computerized perceptual tasks, researchers from UC, Berkeley and the University of Geneva, Switzerland, tested the stereoscopic vision of dressmakers and other professionals and found dressmakers to be the most eagle-eyed.

    The results, published in the June 13 issue of the journal Scientific Reports, show dressmakers to be 80 percent more accurate than non-dressmakers at calculating the distance between themselves and the objects they were looking at, and 43 percent better at estimating the distance between objects.

    “We found dressmakers have superior stereovision, perhaps because of the direct feedback involved with fine needlework,” said study lead author Adrien Chopin, a postdoctoral researcher in visual neuroscience at UC Berkeley.

    What researchers are still determining is whether dressmaking sharpens stereoscopic vision, or whether dressmakers are drawn to the trade because of their visual stereo-acuity, Chopin said.

    To experience what it means to have stereoscopic vision, focus on a visual target. Now blink one eye while still staring at your target. Then blink the other eye. The background should appear to shift position. With stereoscopic vision, the brain’s visual cortex merges the 2D viewpoints of each eye into one 3D image.

    It has generally been assumed that surgeons, dentists and other medical professionals who perform precise manual procedures would have superior stereovision. But previous studies have shown this not to be the case. That spurred Chopin to investigate which professions would produce or attract people with superior stereovision, and led him to dressmakers. A better understanding of dressmakers’ stereoscopic superpowers will inform ongoing efforts to train people with visual impairments such as amblyopia or ‘lazy eye’ to strengthen their stereoscopic vision, Chopin said. 

    In addition to helping people with sight disorders, improved stereoscopic vision may be key to the success of military fighters, athletes and other occupations that require keen hand-eye coordination. An estimated 10 percent of people suffer from some form of stereoscopic impairment, and 5 percent suffer from full stereo blindness, Chopin said.

    For example, the 17th-century Dutch painter Rembrandt, whose self-portraits occasionally showed him with one lazy eye, is thought to have suffered from stereo blindness, rendering him with flat vision. Some vision scientists have posited that painters tend to have poorer stereovision, which gives them an advantage working in 2D.

    For the study, participants viewed objects on a computer screen through a stereoscope and judged the distances between objects, and between themselves and the objects. Researchers recorded their visual precision and found that, overall, dressmakers performed markedly better than their non-dressmaker counterparts in visual acuity.

    In addition to Chopin, co-authors of the study are Dennis Levi of UC Berkeley and Daphné Bavelier of the University of Geneva.

  • Senate Select Committee on Intelligence: Attorney General Jeff Sessions Appears Tuesday To Testify; Jared Kushner Agrees to Be Interviewed

    US Attorney General Jeff Sessions will appear Tuesday [June 13th] at a public hearing before the Senate Select Committee on Intelligence to testify in the investigation into Russian tampering in the 2016 presidential election.

    Attorney General Jeff Sessions, rightAG Jeff Sessions

    “The Attorney General has requested that this hearing  public,” Justice Department spokesman Sarah Isgur Flores said. “He believes it is important for the American people to hear the truth directly from him and looks forward to answering the committee’s questions tomorrow.”

    What time: The hearing begins at 2:30 p.m. ET.

    What channel: CSPAN, CNN, MSNBC and Fox News will be broadcasting the hearing live.  Other networks may also be showing questioning and testimony.

    Live streamed: CSPAN will live stream the testimony at C-Span.org

    Senator Richard Burr (R-NC), Chairman of the Senate Select Committee on Intelligence, and Senator Mark Warner (D-VA), Vice Chairman of the Senate Select Committee on Intelligence, today announced that Senior Advisor to the President Jared Kushner has voluntarily agreed to be interviewed as part of the Committee’s investigation into the Russian activities surrounding the 2016 election. Sens. Burr and Warner made the following statement on the announcement:

    “From the beginning of this investigation we have committed to follow the facts wherever they lead us. This announcement serves to demonstrate that commitment.  Mr. Kushner will certainly not be the last person the committee calls to give testimony, but we expect him to be able to provide answers to key questions that have arisen in our inquiry. The timing of Mr. Kushner’s testimony is still being determined, but will only come after the committee determines that it has received any documents or information necessary to ensure that the meeting is productive for all sides.”

    Jared Kushner, special advisor to the president

    Senior Advisor to the President, Jared Kushner, right 
  • New York State Raises the Minimum Age for Marriage to 17 Years of Age; The Rate of Child Marriage Varies Widely by State

    New York State Assembly Speaker Carl Heastie and Assemblymember Amy Paulin announced the Assembly has passed legislation to raise the minimum age for marriage to 17 years of age. The legislation would prohibit anyone under the age of 17 from marrying and establish a rigorous court approval process for 17-year-olds seeking to marry in New York State (A.5524-A, Paulin). Unlike under existing law, 14, 15 and 16-year-olds would not be permitted to marry under any circumstances.

    “Allowing children as young as 14 to marry in New York is irresponsible and jeopardizes the well-being and future of our youth,” said Speaker Heastie. “This legislation will protect thousands of young people from being exploited and help ensure that anyone in the state seeking a marriage license is doing so on their own free will.”Wedding Bonnet

    “This common sense legislation will help bring an end to forced child marriage in New York State,” said Paulin. “This practice is a violation of human rights that has consistently had a disproportionately discriminatory effect on young girls, inflicting physical and mental health issues, robbing them of educational opportunities, and increasing their risk of experiencing violence.”

    Wedding Bonnet, Philadelphia, circa 1863; Wikimedia Commons

    Under the bill, any 17-year-old seeking a marriage license would be required to get written approval of a justice of the Supreme Court or a judge of the Family Court who presides in the town or city where the application is made. In addition, the court must appoint, for each minor, an attorney who has been trained in domestic violence and forced marriage issues.

    Before issuing any approval, the justice or judge must notify any seventeen-year-old of his or her rights concerning termination of marriage, child and spousal support, domestic violence services, and access to public benefits and other assistance.

    The court would also be required to conduct a review of court-related actions involving the applicants including any warrants, orders of protection and the sex offender registry.

    The court would be required to separately interview each applicant who is seventeen years of age to ensure that:

    • the minor is entering into the marriage by free will;
    • the minor is not being compelled by force, threat, persuasion, fraud, coercion or duress; and
    • the marriage will not endanger the mental, emotional or physical safety of the minor.

    Lastly, upon court approval, each 17-year-old would have the rights of an adult, including the right to enter into contracts, except where a specific constitutional or statutory age threshold or limitation exists, such as exists for voting and for consumption of alcoholic beverages.

  • A New Era for French Art: Poussin, Claude, and French Drawing in the Classical Age

    The French refer to the seventeenth century as the Grand Siècle, or the Great Century. Under the rule of Louis XIII and Louis XIV, the period saw a dramatic increase in French political and military power, the maturation of French courtly life at Versailles, and an unparalleled flourishing of the arts. The exhibit will be on display through October 15, 2017

    Nicholas Poussin, Death of Hippolytus

    Poussin, Claude, and French Drawing in the Classical Age, a new exhibition opening at the Morgan Library & Museum on June 16, explores the work of some of the most celebrated artists of the time. More than fifty drawings largely from the Morgan’s collections — including works by Claude Lorrain, Nicolas Poussin, Jacques Callot, and Charles Le Brun — will be on view. Together they demonstrate the era’s distinctive approach to composition and subject matter, informed by principles of rationalism, respect for the art of classical antiquity, and by a belief in a natural world governed by divine order. The exhibition runs through October 15.  

    Above, Death of Hippolytus, 1645, pen and brown ink and wash over black chalk. The Morgan Library & Museum; Purchased by Pierpont Morgan in 1909

    “The Grand Siècle saw artistic development unlike any before it in France,” said Colin B. Bailey, director of the Morgan Library & Museum. “The visual arts, literature, music, drama, and architecture all prospered. Poussin, Claude, and French Drawing in the Classical Age explore the extraordinary advances in the field of drawing by some of the true masters of the period, advances that provided the foundation for all French art that followed.”

    The Renaissance style in France resulted from a combination of native artistic talent and artists and styles imported from the Italian courts. With the return of French artists trained in Italy, Paris became a locus for artistic activity by the 1630s. The generation of artists working there, Simon Vouet (1590–1649) foremost among them, ushered in a new era for French art. Having established a successful career in Rome, Vouet was recalled to Paris by Louis XIII in 1627 and named first painter to the king, who also engaged him to be his drawing tutor. Vouet and the king developed an intimate relationship, as Portrait of Louis XIII (ca. 1632–35), an informal, frankly executed sheet indicates. Although few drawings from Vouet’s Italian period survive, this portrait of the king made not long after the artist’s return to France reveals the naturalism he learned in Italy and heralds the impact that style would have on French art more generally. Miracle of St. MansuetusThe printmaker Jacques Callot (1592–1635) spent most of his career at Cosimo de’ Medici’s court in Florence before returning to France in 1621 to work at the court at Nancy.

    The Miracle of St. Mansuetus (ca. 1621), produced after the artist’s return, is devoted to a local saint, Mansuetus (d. 375), who was the first Bishop of Toul, in Lorraine (where Callot was born). It shows the saint resuscitating King Leucorus’ son, who had drowned in the river Meuse, and is one of a series of exploratory studies on the theme in preparation for the artist’s 1621 etching. 

    Right: Jacques Callot (1592 —1635), The Miracle of St. Mansuetus, ca. 1621, pen and brown ink and brown wash, over black chalk. The Morgan Library & Museum; Purchased as the gift of Mrs. Kenneth A. Spencer II.

    Courts were centers where philosophy, music, literature, and the fine arts flourished under the patronage of the royal family and wealthy nobles. The drawn portrait was a particularly vibrant tradition of the French court, beginning in the Renaissance and extending through the seventeenth century. These works were collected, assembled into albums, and exchanged as gifts. Portraiture was popular at the courts of Louis XIII and Louis XIV, and many members of the court are recognizable even today through their drawn and printed likenesses. Such depictions reached their apogee in the hands of masters such as Daniel Dumonstier (1574–1646), who was renowned for entertaining his sitters and producing flattering colored chalk portraits. Portrait of a Gentleman of the French Court (1628) is carefully annotated by the artist with the exact date, August 31. However, Dumonstier did not identify the sitter. A possibly contemporary inscription suggests that it depicts a M. de Porchere, but there were at least two poets active at the court with the surname Porchere. It is Dumonstier’s facility with combining colored chalks for a meticulous, lifelike effect in such large scale sheets that sets him apart as a portraitist. III.

  • FDA Has Requested Endo Pharmaceuticals Voluntarily Remove Reformulated Opana ER From the Market

    The US Food and Drug Administration requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone hydrochloride), from the market. After careful consideration, the agency is seeking removal based on its concern that the benefits of the drug may no longer outweigh its risks. This is the first time the agency has taken steps to remove a currently marketed opioid pain medication from sale due to the public health consequences of abuse.Janet Woodcock, FDA MD

    “We are facing an opioid epidemic — a public health crisis, and we must take all necessary steps to reduce the scope of opioid misuse and abuse,” said FDA Commissioner Scott Gottlieb, M.D. “We will continue to take regulatory steps when we see situations where an opioid product’s risks outweigh its benefits, not only for its intended patient population but also in regard to its potential for misuse and abuse.”

    Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research*

    The FDA’s decision is based on a review of all available postmarketing data, which demonstrated a significant shift in the route of abuse of Opana ER from nasal to injection following the product’s reformulation. Injection abuse of reformulated Opana ER has been associated with a serious outbreak of HIV and hepatitis C, as well as cases of a serious blood disorder (thrombotic microangiopathy). This decision follows a March 2017 FDA advisory committee meeting where a group of independent experts voted 18-8 that the benefits of reformulated Opana ER no longer outweigh its risks.

    Opana ER was first approved in 2006 for the management of moderate-to-severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. In 2012, Endo replaced the original formulation of Opana ER with a new formulation intended to make the drug resistant to physical and chemical manipulation for abuse by snorting or injecting. While the product met the regulatory standards for approval, the FDA determined that the data did not show that the reformulation could be expected to meaningfully reduce abuse and declined the company’s request to include labeling describing potentially abuse-deterrent properties for Opana ER. Now, with more information about the risks of the reformulated product, the agency is taking steps to remove the reformulated Opana ER from the market.

    “The abuse and manipulation of reformulated Opana ER by injection has resulted in a serious disease outbreak. When we determined that the product had dangerous unintended consequences, we made a decision to request its withdrawal from the market,” said Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research. “This action will protect the public from further potential for misuse and abuse of this product.”

    The FDA has requested that the company voluntarily remove reformulated Opana ER from the market. Should the company choose not to remove the product, the agency intends to take steps to formally require its removal by withdrawing approval. In the interim, the FDA is making health care professionals and others aware of the particularly serious risks associated with the abuse of this product.

    The FDA will continue to examine the risk-benefit profile of all approved opioid analgesic products and take further actions as appropriate as a part of our response to this public health crisis.

    The FDA, an agency within the US Department of Health and Human Services, promotes and protects the public health by, among other things, assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

    *Dr. Woodcock and her center:

    • evaluate prescription and over the counter drugs before they can be sold and oversee their testing in clinical trials
    • provide health care professionals and patients the information they need to use medicines wisely
    • ensure that drugs, both brand-name and generic, work correctly and that their health benefits outweigh their known risks
    • take action against unapproved, contaminated, or fraudulent drugs that are marketed illegally
  • Sleep Attack: A Cautionary Tale

     by Naomi Cavalier

    Drowsy driving sign

    Looking back, I say to myself: Complacent idiot. Had your head been screwed on right you would have taken any one of several easy steps to safety, such as pulling off the road for a quick doze or turning up the air-conditioner to chill yourself awake or driving a fingernail into a thigh to set yourself ajangle. But no. At the time, all you could think of was: maybe you needed more than a catnap when you reached home, maybe you needed a serious lie-down. Little did you suspect how serious that lie-down would be.

    About a mile from my freeway exit, Pleasant Hill Road divides into Geary and Taylor Roads. I take Geary which is close to my home. I was on Geary driving the speed limit (35 miles an hour) when it happened. The curtain of sleep dropped of its own volition and the world vanished (even as I write this, I gasp). No more than a second or two later I was jolted awake by the impact of my car, a Honda Accord, slamming into a fire hydrant alongside the road. A geyser of water erupted from the hydrant as the car veered and crashed into a telephone pole. 

    Fatigued driving sign in Utah byPhil Konstantin, Wikipedia Commons

    The front of the car was crushed like a balled-up piece of aluminum foil and the shatterproof windshield was shattered. A seat belt helped to protect me from the impact, but my body, normally in pretty good shape for a 72 year old woman, was twisted and thrown hard against the steering wheel striking my right breast. Although I remained conscious and felt no pain (that would come later), I knew I was hurt. 

    Read the rest of Naomi’s article: http://www.seniorwomen.com/articles/articlesNaomiAccident.html

  • Updated: Senate Intel Committee Held FISA Hearing Wednesday; James Comey’s Prepared Senate Testimony for June 8th

    Senator Mark Warner

    **Update: James Comey Prepared Senate Testimony for June 8th, see below**

    Senator Richard Burr (R-NC), Chairman of the Senate Select Committee on Intelligence, and Senator Mark Warner (D-VA), Vice Chairman of the Senate Select Committee on Intelligence, announced that the Committee will hold an open hearing on the Foreign Intelligence Surveillance Act (FISA)* on Wednesday, June 7, 2017, at 10:00 a.m, EST.  Appearing before the Committee was Director of National Intelligence, Daniel Coats; Acting Director of the Federal Bureau of Investigation, Andrew McCabe; National Security Agency Director, Admiral Mike Rogers; and the Department of Justice Deputy Attorney General Rod Rosenstein. 

    The witnesses will provide a comprehensive overview of FISA’s authorities, current oversight mechanisms, and examples of the value this court-authorized collection provides to the United States Intelligence Community.  The hearing will move into closed session following the open session. Above,  Senator Mark Warner

    C-Span has recorded hearings:

    https://www.c-span.org/video/?429451-1/senators-express-frustration-national-security-officials-answers-russia-probe

    Trump Names Wray FBI Director Pick on Eve of Comey Hearing

    Details:  Hearing: Foreign Surveillance Act (FISA)  

    Witnesses:

    Director Daniel Coats of the Office of the Director of National Intelligence

    Acting Director Andrew McCabe of the Federal Bureau of Investigation

    Admiral Mike Rogers, Director of the National Security Agency

    Deputy Attorney General Rod Rosenstein of the Department of Justice.

    Below, Senator Richard Burr

    When: Wednesday, June 7, 2017 at 10:00 a.m, EST.Senator Richard Burr

    Where: Hart Senate Office Building Room 216 

    *https://www.intelligence.senate.gov/legislation

     
    Hearing Type: Open; Date & Time: 
    Thursday, June 8, 2017 – 10:00am EST
    Location: Hart 216

    Witnesses
    Former Director James Comey, Former Director of the Federal Bureau of Investigation, FBI

    Statement for the Record 

    Senate Select Committee on Intelligence

    James B. Comey June 8, 2017

    Chairman Burr, Ranking Member Warner, Members of the Committee.